‘A disease you get when you care for someone’: WHO on the Ebola frontline
‘A Disease You Get When You Care for Someone’: WHO on the Ebola Frontline
A disease you get when you care - As the latest Ebola outbreak enters its second week, the World Health Organization (WHO) has reported a significant rise in cases, estimating 906 suspected infections in the Democratic Republic of Congo (DRC), with 223 confirmed deaths. The agency emphasized the urgency of early detection and community engagement, noting that even as experimental therapies and vaccines are under evaluation, the disease’s spread hinges on timely intervention.
Strain and Spread in a Complex Region
Since 15 May, UN health agencies have been collaborating with the DRC and Uganda to manage the outbreak linked to the rare Bundibugyo strain of the Ebola virus. This strain, which spreads through close physical contact, has posed unique challenges due to its virulence and the region’s socio-political instability. The WHO highlighted that communities must be actively involved in containment efforts, as the disease’s lethality—ranging between 30 and 50 percent in past outbreaks—demands swift action.
“It’s a disease that you get when you care for someone, for your husband or your partner or your child or your mother,” said Anaïs Legand, a WHO Technical Officer, during a briefing in Geneva. “You get it when you want to help someone with symptoms, and this is terrible.”
Ms. Legand underscored the necessity of educating families and friends about the risks of touching sick loved ones. She pointed out that the outbreak’s impact is amplified by cultural practices that prioritize caregiving without protective measures. “Prevention and early access to care are vital,” she stated, stressing that the Bundibugyo strain’s high mortality rate means every delay in diagnosis can cost lives.
Treatment and Prevention in Focus
WHO experts are currently evaluating multiple interventions to combat the disease. For confirmed cases, three therapeutic options have been prioritized for clinical trials: the monoclonal antibodies MBP 134 and maftivimab, as well as the antiviral remdesivir. These treatments aim to improve survival rates by targeting the virus in its early stages. Meanwhile, the oral antiviral obeldesivir is being studied as a preventive measure for individuals exposed to confirmed cases.
Two vaccine candidates have also been identified for further assessment, pending the availability of doses. The agency is working closely with governments in the DRC and Uganda to expand medical facilities and ensure adequate staffing. However, Ms. Legand noted that the primary obstacle is not a lack of resources but limited access to affected populations.
“The issue we have in the field is not necessarily an issue of resources,” she explained. “It’s an issue of access.”
Recent challenges in Ituri province, a key area of the outbreak, have underscored this problem. The airport in Bunia, the capital of the region, has been closed for several days, forcing reliance on humanitarian flights. “One day I got a call from my team telling me there is no fuel,” the WHO expert recounted, illustrating the logistical hurdles in delivering critical supplies to the region.
Despite these setbacks, WHO’s chief, Tedros Adhanom Ghebreyesus, arrived in the DRC on Friday to show solidarity with local communities. In Kinshasa, he urged armed groups in the war-torn eastern region to declare a ceasefire, enabling health workers to reach people in need and contain the virus’s spread. “We are here to remind everyone that the community is not alone,” he said, emphasizing the need for collective action.
Regional Context and Ongoing Efforts
The DRC notified WHO of the outbreak on 15 May, and as of Thursday, 125 confirmed cases had been reported across Ituri, North Kivu, and South Kivu provinces, with 17 deaths. However, the majority of cases remain under investigation, with 906 suspected infections being reviewed as testing capacity increases. In Uganda, the situation is less severe, with seven confirmed cases and one death recorded as of Thursday. WHO stated there is currently no evidence of community transmission in the country, though vigilance remains essential.
Ms. Legand reiterated that community mobilization is crucial to preventing the outbreak from worsening. She cited a recent success in the DRC, where a patient fully recovered and was discharged from a hospital after receiving timely care. “This demonstrates that with the right measures, recovery is possible,” she noted, adding that the key lies in recognizing symptoms early and accessing medical facilities without delay.
The outbreak’s complexity is compounded by the region’s humanitarian crises. In Ituri province alone, 1.2 million people require assistance, and ongoing conflict has disrupted supply chains and delayed response efforts. Food insecurity further strains local resilience, making it harder for families to adopt preventive practices. “The disease thrives in environments where people are already struggling,” Ms. Legand observed, calling for integrated support that addresses both health and socio-economic needs.
While the WHO has not recommended travel or trade restrictions between the DRC and Uganda, it has advised caution for individuals from affected areas. “People who may have been exposed should avoid unnecessary movement, but the current data does not justify widespread bans,” the agency clarified. This balanced approach aims to minimize economic disruption while protecting public health.
Hope Amidst Challenges
Ms. Legand expressed cautious optimism, highlighting that scaling up intensive care units and improving diagnostic capabilities could turn the tide. “We can optimize treatment protocols and ensure communities know how to identify early signs,” she said. This strategy, she argued, is essential for reducing mortality and preventing the outbreak from becoming a regional crisis.
As the outbreak continues, WHO is coordinating with international partners to accelerate research and expand healthcare infrastructure. The agency’s focus remains on bridging the gap between awareness and action, ensuring that families understand the risks of close contact and the importance of isolation. “Education is the first line of defense,” Ms. Legand concluded, urging continued collaboration between health workers and local leaders.
With the situation evolving rapidly, the WHO’s efforts are critical in maintaining hope. The combination of advanced therapies, community-driven prevention, and improved access to care offers a path forward, even in the face of logistical and political challenges. As the outbreak progresses, the agency’s work will determine how effectively the region can combat this deadly disease and protect its most vulnerable populations.